TGFB1 and cancer: However, in advanced cancer, tumor cells can exploit the TGF-β/SMAD pathway to promote cancer progression through the induction of epithelial-mesenchymal transition (EMT) [22], a major step in cancer progression to a more deadly metastatic state.